4//SEC Filing
SNYDER DAVID S 4
Accession 0001493152-23-006389
CIK 0001835022other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:05 PM ET
Size
5.2 KB
Accession
0001493152-23-006389
Insider Transaction Report
Form 4
SNYDER DAVID S
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-27+115,000→ 115,000 totalExercise: $3.85Exp: 2033-02-27→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023.
Documents
Issuer
Coya Therapeutics, Inc.
CIK 0001835022
Entity typeother
Related Parties
1- filerCIK 0001398625
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:05 PM ET
- Size
- 5.2 KB